Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 207

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Full genome screen for Alzheimer disease: Stage II analysis*

Myers, Amanda, Wavrant De‐Vrieze, Fabienne, Holmans, Peter, Hamshere, Marian, Crook, Richard, Compton, Danielle, Marshall, Helen, Meyer, David, Shears, Shantia, Booth, Jeremy, Ramic, Dzanan, Knowles, Heather, Morris, John C., Williams, Nigel, Norton, Nadine, Abraham, Richard, Kehoe, Pat, Williams, Hywel, Rudrasingham, Varuni, Rice, Francis, Giles, Peter, Tunstall, Nigel, Jones, Lesley, Lovestone, Simon, Williams, Julie, Owen, Michael J., Hardy, John, Goate, Alison · 2002 · American Journal of Medical Genetics

Abstract

We performed a two‐stage genome screen to search for novel risk factors for late‐onset Alzheimer disease (AD). The first stage involved genotyping 292 affected sibling pairs using 237 markers spaced at approximately 20 cM intervals throughout the genome. In the second stage, we genotyped 451 affected sibling pairs (ASPs) with an additional 91 markers, in the 16 regions where the multipoint LOD score was greater than 1 in stage I. Ten regions maintained LOD scores in excess of 1 in stage II, on chromosomes 1 (peak B), 5, 6, 9 (peaks A and B), 10, 12, 19, 21, and X. Our strongest evidence for linkage was on chromosome 10, where we obtained a peak multipoint LOD score (MLS) of 3.9. The linked region on chromosome 10 spans approximately 44 cM from D10S1426 (59 cM) to D10S2327 (103 cM). To narrow this region, we tested for linkage disequilibrium with several of the stage II microsatellite markers. Of the seven markers we tested in family‐based and case control samples, the only nominally positive association we found was with the 167 bp allele of marker D10S1217 (chi‐square = 7.11, P = 0.045, df = 1). © 2002 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajmg.10183

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 207

Metadata

Authors
Myers, A., Wavrant De‐Vrieze, F., Holmans, P., Hamshere, M., Crook, R., Compton, D., Marshall, H., Meyer, D., Shears, S., Booth, J., Ramic, D., Knowles, H., Morris, J. C., Williams, N., Norton, N., Abraham, R., Kehoe, P., Williams, H., Rudrasingham, V., Rice, F., Giles, P., Tunstall, N., Jones, L., Lovestone, S., Williams, J., Owen, M. J., Hardy, J., & Goate, A.
Venue
American Journal of Medical Genetics
Publisher
Wiley
Published
2002-03-08
Volume
114
Issue
2
Pages
235-244
ISSN
  • 0148-7299 (ISSN-L)
  • 1096-8628
OpenAlex
W1966741769
Cited by
207
References
5
FWCI
15.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Full genome screen for Alzheimer disease: Stage II analysis*. https://app.cochat.ai/papers/10.1002/ajmg.10183
The paper
Myers, A., Wavrant De‐Vrieze, F., Holmans, P., Hamshere, M., Crook, R., Compton, D., Marshall, H., Meyer, D., Shears, S., Booth, J., Ramic, D., Knowles, H., Morris, J. C., Williams, N., Norton, N., Abraham, R., Kehoe, P., Williams, H., Rudrasingham, V., . . . Goate, A. (2002). Full genome screen for Alzheimer disease: Stage II analysis*. American Journal of Medical Genetics. https://doi.org/10.1002/ajmg.10183

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.